Application of the WHO Reporting System for Soft Tissue Cytopathology in Bone and Soft Tissue FNAs : Diagnostic Accuracy and Risk of Malignancy Analysis
- 13 July 2026
- journal article
- Published by Wiley in Diagnostic Cytopathology
- Vol. 54 (11) , 798-804
Abstract
Introduction: Recently, a standardized reporting system for soft tissue cytopathology was introduced. The aim is to evaluate the diagnostic utility of FNA in the diagnosis of bone and soft tissue lesions by comparing the cytological and histopathological diagnoses in a large group of cases and to determine the risk of malignancy (ROM) rates according to the World Health Organization (WHO) Reporting System for Soft Tissue Cytopathology. Materials and Methods: The pathology databases were searched for cases that underwent FNA for bone and soft tissue lesions between 2020 and 2023. Only cases that had available histological follow‐up were included. The FNAs are categorized as nondiagnostic (ND), benign, atypical, soft tissue neoplasm of uncertain malignant potential (STNUMP), suspicious for malignancy (SM), malignant (primary/metastatic) according to WHO Reporting System for Soft Tissue Cytopathology. The risk of malignancy (ROM) was calculated for each group. Results: The study consisted of 427 cases, including 30 ND (7%), 322 benign (75.4%), 19 atypical (4.5%), 7 STNUMP (1.6%), 5 SM (1.2%), and 44 malignant (10.3%). The ROM rates were 16.6%, 1.8%, 57.9%, 28.5%, 80%, and 100% for the groups: ND, benign, atypical, STNUMP, SM, and malignant, respectively. The diagnostic accuracy, sensitivity, and specificity of FNA in all bone and soft tissue lesions were 98.6%, 92.3%, and 100%, respectively. Conclusion: We conclude that FNA is a simple and accurate technique for assessment of bone and soft tissue lesions. The WHO Soft Tissue Cytopathology Reporting System could improve communication among pathologists and clinicians, simplify clinical management of patients, and support further research in soft tissue cytology.Keywords
This publication has 18 references indexed in Scilit:
- Spindle cell lesions in cytology: Risks of malignancy and application of the upcoming World Health Organization Reporting System for Soft Tissue CytopathologyCancer Cytopathology, 2026
- Application of the Milan and IAC–IARC–WHO Systems in diagnosing soft tissue and bone tumors of the salivary glands: The Institut Curie experienceCancer Cytopathology, 2025
- Diagnostic performance of fine‐needle aspiration in soft tissue tumors: Application of the World Health Organization System for Reporting Soft Tissue Cytopathology and risk of malignancy assessmentCancer Cytopathology, 2024
- Reappraisal of bone and soft tissue cytopathology classification using the modified Milan systemCancer Cytopathology, 2024
- World Health Organization Reporting System for Soft Tissue Cytopathology: Risk of malignancy and reproducibility of categories among observersDiagnostic Cytopathology, 2024
- Diagnostic accuracy and clinical utility of biopsy in musculoskeletal lesions: A comparison of fine‐needle aspiration, core, and open biopsy techniquesDiagnostic Cytopathology, 2014
- Diagnostic accuracy and limitations of fine‐needle aspiration cytology of bone and soft tissue lesionsCancer Cytopathology, 2010
- Reliability of fine‐needle aspiration biopsy in the initial diagnosis of soft‐tissue lesionsDiagnostic Cytopathology, 2002
- Subgrouping and grading of soft‐tissue sarcomas by fine‐needle aspiration cytology: A histopathologic correlation studyDiagnostic Cytopathology, 2001
- Fine-needle aspiration cytology of boneCancer, 2000